Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT devices in neovascular age-related macular degeneration

Aims: To evaluate the reliability of different optical coherence tomography (OCT) devices and scanning patterns in the assessment of retinal thickness and segmentation performance in neovascular age-related macular degeneration (nAMD). Methods: 28 eyes with nAMD and 10 healthy eyes were imaged using conventional time domain (TD) OCT as well as three spectral-domain (SD) OCT systems. Radial scans of 6 mm in size were compared between Stratus and Topcon OCT, in addition to raster scans of all three SD-OCT devices. Retinal thickness values were analysed. Results: Spectralis SD-OCT demonstrated the highest values of all OCT devices in central millimetre thickness (CMMT), and Topcon OCT raster scans showed the lowest values. Significant correlations could be found between the CMMT measurements of Cirrus and Spectralis OCT (r = 0.87). Analyses showed best segmentation for Cirrus and Spectralis SD-OCTs. Cirrus 200×200×1024 scans showed 4% and Stratus OCT 38% moderate or severe segmentation errors. Conclusion: Retinal thickness values were generally higher in SD-OCT analysis. Different performances of automatic retinal thickness analysis indicate the potential of different software algorithms to quantify retinal morphology in nAMD. Further development of current algorithms may improve quantification of retinal thickness detection in the future even further.

[1]  Maciej Wojtkowski,et al.  High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. , 2006, Ophthalmology.

[2]  E Reichel,et al.  Characterization of epiretinal membranes using optical coherence tomography. , 1996, Ophthalmology.

[3]  L. Labree,et al.  Errors in retinal thickness measurements obtained by optical coherence tomography. , 2006, Ophthalmology.

[4]  W. Brannath,et al.  Optical coherence tomography guided retreatment of photodynamic therapy , 2005, British Journal of Ophthalmology.

[5]  R Ritch,et al.  Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. , 1998, Ophthalmic surgery and lasers.

[6]  P. Ferreri,et al.  Intravitreal Triamcinolone Acetonide: Valuation of Retinal Thickness Changes Measured by Optical Coherence Tomography in Diffuse Diabetic Macular Edema , 2004, European journal of ophthalmology.

[7]  J. Duker,et al.  Imaging of macular diseases with optical coherence tomography. , 1995, Ophthalmology.

[8]  U. Schmidt-Erfurth,et al.  Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases. , 2005, Investigative ophthalmology & visual science.

[9]  G. Wollstein,et al.  Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. , 2004, Investigative ophthalmology & visual science.

[10]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.

[11]  S. Harding,et al.  Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study , 2005, British Journal of Ophthalmology.

[12]  J. Fujimoto,et al.  Optical Coherence Tomography , 1991 .

[13]  G. Soubrane,et al.  [Optical coherence tomography and ARMD]. , 2004, Journal francais d'ophtalmologie.

[14]  J. Ruiz-Moreno,et al.  Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3 , 2003, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  A Erginay,et al.  Reproducibility of retinal mapping using optical coherence tomography. , 2001, Archives of ophthalmology.

[16]  R. Tibrewala,et al.  VISUAL IMPROVEMENT FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION , 2006, Retina.

[17]  Miguel J Maldonado,et al.  Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. , 2005, American journal of ophthalmology.

[18]  Maciej Wojtkowski,et al.  Ophthalmic imaging by spectral optical coherence tomography. , 2004, American journal of ophthalmology.

[19]  A. Augustin,et al.  TRIPLE THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION: Verteporfin PDT, Bevacizumab, and Dexamethasone , 2007, Retina.

[20]  T. Cox,et al.  Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. , 2002, Archives of ophthalmology.

[21]  J. Duker,et al.  Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.

[22]  Arthur D. Fu,et al.  INTRAVITREAL BEVACIZUMAB FOR PREVIOUSLY TREATED CHOROIDAL NEOVASCULARIZATION FROM AGE-RELATED MACULAR DEGENERATION , 2007, Retina.